07:45 AM EDT, 07/21/2025 (MT Newswires) -- Biogen (BIIB) said Monday it plans to invest an additional $2 billion in its manufacturing facilities at North Carolina's Research Triangle Park, building on nearly $10 billion invested in the area to date.

The expansion will support the growth of its late-stage clinical pipeline across multiple modalities at its two RTP campuses, the company said.

The investment will enhance antisense oligonucleotide capabilities, establish clinical and commercial multi-platform fill-finish operations, and modernize manufacturing technologies and controls through advanced automation and artificial intelligence, it added.